Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia.
Matsuda K, Sakashita K, Taira C, Tanaka-Yanagisawa M, Yanagisawa R, Shiohara M, Kanegane H, Hasegawa D, Kawasaki K, Endo M, Yajima S, Sasaki S, Kato K, Koike K, Kikuchi A, Ogawa A, Watanabe A, Sotomatsu M, Nonoyama S, Koike K.
Matsuda K, et al. Among authors: koike k.
Br J Haematol. 2010 Feb;148(4):593-9. doi: 10.1111/j.1365-2141.2009.07968.x. Epub 2009 Oct 29.
Br J Haematol. 2010.
PMID: 19874312
Free article.